Emmaus Life Sciences, Inc. insiders have been one-way buyers this past year: one person put roughly $18,000 into the stock and nobody sold in open-market trades.
Biggest single buyer: LEE WILLIS C, CEO, with roughly $5,686. Notably, at least one C-suite executive was among the buyers.
Looking at the quarterly pattern: Last full quarter: net buying by insiders. Insiders bought in 3 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | LEE WILLIS C | CEO | Buy | 100,000 | $0.05 | $5K | SEC |
| Sep 2, 2026 | LEE WILLIS C | CEO | Buy | 50,000 | $0.05 | $2K | SEC |
| Sep 2, 2026 | LEE WILLIS C | CEO | Buy | 46,000 | $0.04 | $2K | SEC |
| Sep 2, 2026 | LEE WILLIS C | CEO | Buy | 94,767 | $0.06 | $6K | SEC |
| Sep 2, 2026 | LEE WILLIS C | CEO | Buy | 70,000 | $0.02 | $1K | SEC |
| Sep 2, 2026 | LEE WILLIS C | CEO | Buy | 170,000 | $0.01 | $2K | SEC |
| Sep 18, 2024 | Lim Seah H. | Director | Buy | 20,000 | $0.04 | $800 | SEC |
| Feb 29, 2024 | LEE WILLIS C | COO | Buy | 77,000 | $0.13 | $10K | SEC |
| Feb 29, 2024 | LEE WILLIS C | COO | Buy | 15,000 | $0.12 | $2K | SEC |
| Feb 29, 2024 | LEE WILLIS C | COO | Buy | 10,000 | $0.13 | $1K | SEC |
| Feb 29, 2024 | LEE WILLIS C | COO | Buy | 13,200 | $0.12 | $2K | SEC |
| Jan 3, 2024 | LEE WILLIS C | COO | Buy | 12,000 | $0.12 | $1K | SEC |
| Jan 3, 2024 | LEE WILLIS C | COO | Buy | 1,100 | $0.12 | $132 | SEC |
| Jan 3, 2024 | LEE WILLIS C | COO | Buy | 6,000 | $0.15 | $900 | SEC |
| Jan 3, 2024 | LEE WILLIS C | COO | Buy | 6,500 | $0.21 | $1K | SEC |
In the last 12 months Emmaus Life Sciences, Inc. insiders made open-market purchases worth about $18,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in EMMA was filed on 2026-09-02.
No congressional trades in EMMA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).